Adaptive Biotechnologies is a pioneering company dedicated to transforming the diagnosis and treatment of immune-mediated diseases, including cancer and autoimmune disorders, through innovative applications of DNA sequencing. By leveraging advanced technologies and partnerships, such as their collaboration with Microsoft, Adaptive aims to create a universal map of the human immune system, facilitating the development of accessible blood-based diagnostics. The company fosters a collaborative environment where employees can make a meaningful impact on patients' lives while working at the forefront of immune medicine.